Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
1.100
-0.010 (-0.90%)
Dec 19, 2025, 4:00 PM EST - Market closed
Talphera Revenue
Talphera had revenue of $1,000.00 in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $28.00K, down -90.04% year-over-year.
Revenue (ttm)
$28.00K
Revenue Growth
-90.04%
P/S Ratio
1,831.09
Revenue / Employee
$2,154
Employees
13
Market Cap
51.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 651.00K | -2.69M | -80.51% |
| Dec 31, 2022 | 3.34M | 523.00K | 18.56% |
| Dec 31, 2021 | 2.82M | -2.60M | -47.97% |
| Dec 31, 2020 | 5.42M | 3.13M | 136.61% |
| Dec 31, 2019 | 2.29M | 138.00K | 6.42% |
| Dec 31, 2018 | 2.15M | -5.84M | -73.10% |
| Dec 31, 2017 | 8.00M | -9.36M | -53.94% |
| Dec 31, 2016 | 17.36M | -1.91M | -9.89% |
| Dec 31, 2015 | 19.26M | 14.05M | 269.24% |
| Dec 31, 2014 | 5.22M | -24.29M | -82.32% |
| Dec 31, 2013 | 29.50M | 27.11M | 1,132.33% |
| Dec 31, 2012 | 2.39M | 1.32M | 123.32% |
| Dec 31, 2011 | 1.07M | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TLPH News
- 5 weeks ago - Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 - PRNewsWire
- 2 months ago - Talphera Announces the Appointment of Joe Todisco to Board of Directors - PRNewsWire
- 3 months ago - CorMedix Announces Strategic Minority Investment in Talphera - GlobeNewsWire
- 3 months ago - Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market - PRNewsWire
- 4 months ago - Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial - PRNewsWire
- 4 months ago - Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript - Seeking Alpha